34 related articles for article (PubMed ID: 20419195)
1. trans-Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents.
Sakamaki Y; Ahmadi Mirsadeghi H; Fereidoonnezhad M; Mirzaei F; Moghimi Dehkordi Z; Chamyani S; Alshami M; Abedanzadeh S; Shahsavari HR; Beyzavi MH
Chempluschem; 2019 Oct; 84(10):1525-1535. PubMed ID: 31943935
[TBL] [Abstract][Full Text] [Related]
2. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
3. A Platinum(II) Complex of Heptamethine Cyanine for Photoenhanced Cytotoxicity and Cellular Imaging in Near-IR Light.
Mitra K; Lyons CE; Hartman MCT
Angew Chem Int Ed Engl; 2018 Aug; 57(32):10263-10267. PubMed ID: 29939482
[TBL] [Abstract][Full Text] [Related]
4. Photoluminescent DNA binding and cytotoxic activity of a platinum(II) complex bearing a tetradentate β-diketiminate ligand.
Hope JM; Wilson JJ; Lippard SJ
Dalton Trans; 2013 Mar; 42(9):3176-80. PubMed ID: 23143731
[TBL] [Abstract][Full Text] [Related]
5.
Harlepp S; Chardon E; Bouché M; Dahm G; Maaloum M; Bellemin-Laponnaz S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461928
[TBL] [Abstract][Full Text] [Related]
6. Not the usual suspect - an unexpected organometallic product during the synthesis of cytotoxic platinum(II) complexes.
Maier T; Wutschitz J; Gajic N; Hejl M; Cseh K; Mai S; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2023 Nov; 52(44):16326-16335. PubMed ID: 37855721
[TBL] [Abstract][Full Text] [Related]
7. Advancements in steroidal Pt(II) & Pt(IV) derivatives for targeted chemotherapy (2000-2023).
Sheikh HK; Ortiz CJC; Arshad T; Padrón JM; Khan H
Eur J Med Chem; 2024 May; 271():116438. PubMed ID: 38685141
[TBL] [Abstract][Full Text] [Related]
8. Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer.
Maji M; Karmakar S; Ruturaj ; Gupta A; Mukherjee A
Dalton Trans; 2020 Feb; 49(8):2547-2558. PubMed ID: 32022814
[TBL] [Abstract][Full Text] [Related]
9. Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.
Gorle AK; Haselhorst T; Katner SJ; Everest-Dass AV; Hampton JD; Peterson EJ; Koblinski JE; Katsuta E; Takabe K; von Itzstein M; Berners-Price SJ; Farrell NP
Angew Chem Int Ed Engl; 2021 Feb; 60(6):3283-3289. PubMed ID: 33174390
[No Abstract] [Full Text] [Related]
10. Picoplatin binding to proteins: X-ray structures and mass spectrometry data on the adducts with lysozyme and ribonuclease A.
Ferraro G; Lyčková T; Massai L; Štarha P; Messori L; Merlino A
Dalton Trans; 2024 May; 53(20):8535-8540. PubMed ID: 38727007
[TBL] [Abstract][Full Text] [Related]
11. Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting.
Kejík Z; Koubková N; Krčová L; Sýkora D; Abramenko N; Veselá K; Kaplánek R; Hajduch J; Houdová Megová M; Bušek P; Šedo A; Lacina L; Smetana K; Martásek P; Jakubek M
Bioorg Chem; 2023 Dec; 141():106816. PubMed ID: 37716274
[TBL] [Abstract][Full Text] [Related]
12. Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation.
Menon V; Katner SJ; Lee DE; Peterson EJ; Koblinski JE; Farrell NP
J Inorg Biochem; 2024 Mar; 252():112475. PubMed ID: 38199050
[TBL] [Abstract][Full Text] [Related]
13. Suppressing Platinum Electrocatalyst Degradation via a High-Surface-Area Organic Matrix Support.
Smiljanić M; Bele M; Moriau LJ; Vélez Santa JF; Menart S; Šala M; Hrnjić A; Jovanovič P; Ruiz-Zepeda F; Gaberšček M; Hodnik N
ACS Omega; 2022 Feb; 7(4):3540-3548. PubMed ID: 35128261
[TBL] [Abstract][Full Text] [Related]
14. The interactions of novel mononuclear platinum-based complexes with DNA.
Johnson BW; Burgess MW; Murray V; Aldrich-Wright JR; Temple MD
BMC Cancer; 2018 Dec; 18(1):1284. PubMed ID: 30577821
[TBL] [Abstract][Full Text] [Related]
15. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction.
Marqués-Gallego P; Gamiz-Gonzalez MA; Fortea-Pérez FR; Lutz M; Spek AL; Pevec A; Kozlevčar B; Reedijk J
Dalton Trans; 2010 Jun; 39(21):5152-8. PubMed ID: 20419195
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
17. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
19. Target-selective delivery and activation of platinum-based anticancer agents.
Ding S; Bierbach U
Future Med Chem; 2015; 7(7):911-27. PubMed ID: 26061108
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
